New analysis of registry data suggest pregnant persons are not facing particularly worse pregnancy nor neonatal outcomes after mRNA vaccination.
Investigators discovered that the variant was in many other countries before it was discovered and created a tool to help detect emerging variants in the future....
Molecular tools like RNA-activated RNases could be a potential new paradigm for therapeutics.
Neurotropic capacities of SARS-CoV-2 makes it a potent factor to cause acute and late neurological effects.
Unlike the influenza A virus H1N1 2009 pandemic, pregnancy was not identified as a high-risk condition for SARS-CoV-2.
Smaller cities and towns with a short supply of intensive care units and tight budgets need effective precautionary measures.
The virus may have been cleared by the time of death or viral copy numbers were below the level of detection.
New reports show COVID-19 reinfection is possible, but other data suggest many patients will likely be protected from reinfection for many months, or even years....